ACTA ENDOCRINOLOGICA-BUCHAREST, vol.18, no.4, pp.458-465, 2022 (SCI-Expanded, Scopus)
Background. Heterozygous gain-of-function mutations in the glucokinase (GCK) gene cause hyperinsulinaemic hypoglycaemia (GCK-HI), while loss-of-function mutations lead to a monogenic type of diabetes (GCK-MODY). We, herein, report a heterozygous GCK gene mutation in a large family with GCK-MODY and insulinoma in one individual from the same family.